Pamela Spikner Appointed Chief Accounting Officer at BD to Strengthen Financial Leadership

BD Welcomes Pamela Spikner as Chief Accounting Officer and Controller

BD (Becton, Dickinson and Company), a prominent player in global medical technology, has recently announced the appointment of Pamela Spikner as the new Chief Accounting Officer and Controller. Effective January 20, 2025, Spikner will assume her role as Senior Vice President, marking a significant step in BD's ongoing commitment to enhancing its financial operations.

A Wealth of Experience

Pamela Spikner brings over 25 years of extensive experience in corporate finance and accounting to her new role at BD. Previously, she served as the Chief Accounting Officer at R1 RCM, Inc., where she was responsible for overseeing financial reporting and compliance. During her tenure, she implemented strategic financial planning initiatives and operational efficiency programs that significantly bolstered the company's financial infrastructure. This experience is expected to be crucial as BD continues to strengthen its financial leadership.

Before joining R1 RCM, Spikner held a variety of accounting leadership positions at Exelon Corporation, one of the Fortune 200 companies and the largest utility company in the United States. Notably, she served as the Assistant Corporate Controller at Hill-Rom Holdings, Inc. from July 2019 to July 2021, further underscoring her robust background in the medical industry.

Spikner began her professional journey in the audit practice at PwC, where she specialized in clients from the healthcare and insurance sectors. Her comprehensive experience across various roles and industries positions her as a vital asset to BD's finance organization.

Commitment to Leadership

Chris DelOrefice, BD's Executive Vice President and Chief Financial Officer, expressed confidence in Spikner's capabilities, stating, "Pam has a proven track record of leadership in corporate finance and accounting, with a deep passion for building and leading high-performing teams." Her appointment is seen as pivotal for incorporating strong financial governance and vision within the company.

The Future of BD

Spikner's expertise aligns perfectly with BD's overall mission to improve medical discovery, diagnostics, and the delivery of care. The company prides itself on supporting healthcare providers by developing innovative technologies and solutions that enhance safety and efficiency in patient care.

BD employs more than 70,000 individuals worldwide, all dedicated to addressing some of the most pressing global health issues. With Spikner at the helm of financial oversight, BD is expected to continue its trajectory of growth and innovation, further advancing its role in the medical technology sector.

For more information about BD and its initiatives, visit bd.com or connect with the company on LinkedIn or social media platforms to stay updated on the latest developments and innovations in healthcare technology.